Economic Development

Diatherix Laboratories acquires diagnostic testing patent

News Outlet: 
PRNewswire, GenomeWeb Daily News
Date published: 
August 6, 2013
Huntsville, Ala. -- DIATHERIX Laboratories, Inc., today announced that it has acquired the patent to Tem-PCR, a diagnostic testing technology that allows for rapid identification of multiple infectious disease organisms. The acquisition from QIAGEN, a leading global provider of molecular sample and assay technologies, follows a multi-year agreement through which DIATHERIX licensed Tem-PCR from QIAGEN. Terms of the deal were not disclosed.
 

Serina announces partnership with Scripps Research Institute for drug development

 
HUNTSVILLE, Ala. -- Serina Therapeutics announced today that the company has entered into a research agreement with the Scripps Research Institute for development of polymer-antibody drug conjugates. 

Retired Lt. Gen. Joseph M. Cosumano named incoming CFDRC president


Huntsville, Ala. – Joseph M. Cosumano joins CFD Research Corporation (CFDRC) as president, effective Feb. 1, 2013. Cosumano’s military and civilian experience in key modernization efforts make him a perfect fit to lead CFDRC as it continues to make significant discoveries and applications. 
 

Serina Therapeutics announces agreement with AstraZeneca for development of polymer


Serina Therapeutics, Inc. has developed a proprietary, patented polymer technology for drug development and announced an agreement with AstraZeneca to develop the polyoxazoline (POZ) polymer therapeutic with an AstraZeneca proprietary compound. The nature of the POZ therapeutic and the terms of the agreement were not immediately disclosed. 

Reuters highlights CFDRC in vitro tumor model

News Outlet: 
Reuters
Date published: 
December 11, 2012

 

CFD Research Corporation has been awarded a $1.3 million grant from the National Institutes of Health to develop their novel in vitro tumor model. SynVivo-Tumor replicates the tumor microenvironment with physiologically and morphologically realistic microvasculature including endothelial cell-lined leaky vessels and 3D solid tumors. Tumor drug delivery is a complex phenomenon affected by several elements in addition to physico-chemical properties. 
 
"Current in vitro models of tumor drug delivery are oversimplified and show poor correlation with in vivo performance," said Prabhakar Pandian, Ph.D., CFDRC principal investigator. "Our novel platform mimics the in vivo environment with physiologically relevant flow resulting in endothelial cell lined capillary vessels and 3D solid tumors. Most importantly, the SynVivo-Tumor platform enables real-time, quantitative assessment of the performance of drug delivery vehicles."

Popular Science lists IDair's fingerprint scanner in its "best of" list

News Outlet: 
Popular Science/The Huntsville Times
Date published: 
November 27, 2012

 

Huntsville, Ala. - A Huntsville company whose fingerprint scanner can photographically capture fingerprints from as far as six meters has been named to Popular Science's "Best of What's New" list.
 
The product, AIRprint, is made by IDair, a HudsonAlpha-based spinoff of Advanced Optical Systems. Most of IDair's customers are military, but this summer, a 24-hour fitness center was beta-testing the system as a way to stop people from sharing access keys without paying. The product, according to Popular Science, costs $5,000.
 
Click here to see the follow-up story on this HudsonAlpha resident associate company in the Huntsville Times. To see the product in Popular Science, click here

iXpressGenes International Space Station grant featured in The Huntsville Times

News Outlet: 
The Huntsville Times
Date published: 
November 11, 2012

 

HUNTSVILLE, Alabama -- A company at the HudsonAlpha Institute for Biotechnology has won one of the first three grants from the center managing research on the International Space Station for science that could lead to new and more effective medicines. Also funded this month is work being done at the University of Alabama in Birmingham.
 
The Huntsville company, iXpress Genes, Inc., proposes to grow large protein crystals in space for studies that could lead to new understanding of molecules. That understanding is a key to designing new medications that don't cause side effects when they interact with molecules in the body. 

Two former Diatherix interns to present project at international health care conference

Two chemical and biomolecular engineering seniors, Doug Woodcock and Brett Taylor, are flying to England this month to attend an international health care conference and present the results of an engineering management project they completed last spring.

 
Their project was to analyze the positive impact of a new method for screening for drug resistant staph bacteria before surgery called Tem-PCR developed by Diatherix Laboratories in Huntsville, Ala. and the Kettering Medical Center in Ohio.
 
Read the rest of the story on Vanderbilt's website
 

CASIS announces first grants for protein crystallization

iXpress Genes, a HudsonAlpha resident associate company, will have research project on board International Space Station

KENNEDY SPACE CENTER, FL. (November 1, 2012) – The Center for the Advancement of Science in Space (CASIS), the nonprofit organization promoting and managing research on board the International Space Station (ISS) U.S. National Laboratory, today announced its first research grant awards totaling $1.2 million for three projects advancing protein crystallization in microgravity.

click here for the entire release from CASIS

 

CFD Research Corporation Selected to Present at WBT Innovation Marketplace in San Diego

CFDRC among 130 companies and technologies seeking capital, acquisition or licensing partners during WBT 2012

Syndicate content